Hawaii 2022 Regular Session

Hawaii Senate Bill SB1186

Introduced
1/27/21  
Refer
1/29/21  
Refer
2/3/21  
Report Pass
2/17/21  

Caption

Relating To The Uniform Controlled Substances Act.

Impact

The proposed changes are expected to enhance law enforcement's ability to regulate and manage potentially dangerous substances. By aligning state regulations with federal updates, the bill aims to improve the efficiency in tackling the misuse of new synthetic drugs that are not adequately covered under the current law. This alignment is crucial to prevent loopholes that allow certain substances to evade regulation and pose significant risks to public health.

Summary

Senate Bill 1186 aims to amend the Uniform Controlled Substances Act in Hawaii by updating the schedules of controlled substances to align with recent federal regulations. This bill specifically addresses the inclusion of various new substances that have emerged in response to the opioid crisis and the evolving landscape of drug use, aiming to improve regulation and enforcement of drug-related issues. It seeks to ensure that state law effectively reflects federal law to tackle the critical issue of substance abuse more effectively.

Sentiment

The overall sentiment around SB1186 is generally supportive, particularly among members of the Senate Health Committee, who recognize the urgent need to address the escalating problem of substance abuse in the state. While proponents advocate for proactive measures against substance misuse, there are concerns about the potential implications for patients with legitimate medical needs, particularly those using prescribed opioids for pain management. Advocates insist on the necessity of maintaining both regulation and access.

Contention

Notable points of contention include the balance between enforcement and accessibility. Some legislators and public health advocates voiced apprehension about the broad application of criminal penalties to new substances, fearing that it could negatively affect individuals seeking treatment for addiction or those who require pain management. Ensuring that the amendments do not inadvertently criminalize medical users while targeting illicit drug use remains a central concern in discussions surrounding the bill.

Companion Bills

No companion bills found.

Similar Bills

HI SB3141

Relating To The Uniform Controlled Substances Act.

HI HB2173

Relating To The Uniform Controlled Substances Act.

ND SB2064

The scheduling of controlled substances; and to declare an emergency.

IN SB0379

Drug schedules.

IN SB0209

Drug schedules.

SD SB35

Modify substances listed on the controlled substances schedule and to declare an emergency.

KS SB9

Adding tianeptine to schedule I of the uniform controlled substances act.